Marta Alonso-Montero

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Immune status modifies the association between plasma zonulin-1 and skeletal-related events in treated HIV: a case-cohort study.

Immune status modifies the association between plasma zonulin-1 and skeletal-related events in treated HIV: a case-cohort study.

Journal: The journals of gerontology. Series A, Biological sciences and medical sciences

Published: March 26, 2026

Hodgkin and non-Hodgkin lymphomas in the post-antiretroviral therapy era according to HIV virological suppression.

Hodgkin and non-Hodgkin lymphomas in the post-antiretroviral therapy era according to HIV virological suppression.

Journal: HIV medicine

Published: January 27, 2026

Elevated Zonulin-1 is Associated With an Increased Risk of Non-AIDS-Defining Cancers in People With HIV With Suboptimal Immune Recovery: A Case-Cohort Study.

Elevated Zonulin-1 is Associated With an Increased Risk of Non-AIDS-Defining Cancers in People With HIV With Suboptimal Immune Recovery: A Case-Cohort Study.

Journal: Journal of medical virology

Published: January 07, 2026

Elevated Plasma GDF-15 Levels Are Associated with Aging, Multimorbidity, and Tobacco Exposure in People with HIV.

Elevated Plasma GDF-15 Levels Are Associated with Aging, Multimorbidity, and Tobacco Exposure in People with HIV.

Journal: Infectious diseases and therapy

Published: November 12, 2025

Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study).

Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study).

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 24, 2025

Age-standardized comparison of coronary artery disease, stroke incidence, and all-cause mortality between people living with HIV and the general population in Spain.

Age-standardized comparison of coronary artery disease, stroke incidence, and all-cause mortality between people living with HIV and the general population in Spain.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: June 23, 2025

Clinical and immunovirological status in children, adolescents and young adults with early-life-acquired HIV: a Spanish multi-cohort analysis since 2020.

Clinical and immunovirological status in children, adolescents and young adults with early-life-acquired HIV: a Spanish multi-cohort analysis since 2020.

Journal: The Journal of antimicrobial chemotherapy

Published: April 30, 2025

Low-effort HIV training in Spanish primary care: Long-term impact on testing and diagnosis.

Low-effort HIV training in Spanish primary care: Long-term impact on testing and diagnosis.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: April 22, 2025

Markers of inflammation and immune dysfunction and non-AIDS cancer risk in adults with HIV.

Markers of inflammation and immune dysfunction and non-AIDS cancer risk in adults with HIV.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: April 07, 2025

Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023).

Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023).

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 27, 2025

Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol.

Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol.

Journal: BMJ open respiratory research

Published: April 03, 2024

Laboral cranio-facial cellulitis with perichondritis and external otitis, a case report.

Laboral cranio-facial cellulitis with perichondritis and external otitis, a case report.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: November 30, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026